Skip to main content
The Markets by Proactive
Go to Proactive Australia

Archive

Faron Pharmaceuticals Shareholder Q&A

Faron Pharmaceuticals Shareholder Q&A

Faron Pharmaceuticals' (LON:FARN) Markku Jalkanen (CEO) answers shareholder questions following his live Proactive One2One investment presentation.

Jalkanen address queries on a potential US listing, US Department of Defense and working with Kaiku Health.

If you missed the live presentation, you can see it here: https://youtu.be/eo52gQnF4w4